Responses
ORIGINAL ARTICLES
Diagnostic clinical application of two-color fluorescence in situ hybridization that detects chromosome 1 and 17 alterations to direct touch smear and liquid-based thin-layer cytologic preparations of endometrial cancers
Compose a Response to This Article
Other responses
No responses have been published for this article.